Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt Adjusted fees for applications to European Medicines Agency from 1 April 2012 17 februar 2012NewsMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 February 2012 17 februar 2012NewsHuman European Medicines Agency recommends conditional approval of Pixuvri (pixantrone) for relapsed or refractory aggressive non-Hodgkin's B-cell lymphoma 17 februar 2012Press releaseHumanMedicines European Medicines Agency recommends new anti-malaria treatment for use outside the European Union 17 februar 2012Press releaseHumanMedicines European Medicines Agency concludes review of dose recommendations for anti-tuberculosis medicines used in children 17 februar 2012Press releaseHumanMedicinesPaediatrics European Medicines Agency recommends lifting suspension of aprotinin 17 februar 2012Press releaseHumanMedicines European Medicines Agency recommends new contraindications and warnings for aliskiren-containing medicines 17 februar 2012Press releaseHumanMedicines European Medicines Agency gives final recommendations for 12 centrally authorised medicines manufactured at Ben Venue Laboratories 16 februar 2012Press releaseHumanMedicines European Medicines Agency informs doctors and patients about drug interaction between Victrelis and ritonavir-boosted HIV protease inhibitors 16 februar 2012Press releaseHumanMedicines European Medicines Agency confirms positive benefit-risk balance of orlistat-containing medicines 16 februar 2012Press releaseHumanMedicines 1 … 255 256 257 258 259 Page 259 of 380 260 261 262 263 … 380
Adjusted fees for applications to European Medicines Agency from 1 April 2012 17 februar 2012NewsMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 February 2012 17 februar 2012NewsHuman
European Medicines Agency recommends conditional approval of Pixuvri (pixantrone) for relapsed or refractory aggressive non-Hodgkin's B-cell lymphoma 17 februar 2012Press releaseHumanMedicines
European Medicines Agency recommends new anti-malaria treatment for use outside the European Union 17 februar 2012Press releaseHumanMedicines
European Medicines Agency concludes review of dose recommendations for anti-tuberculosis medicines used in children 17 februar 2012Press releaseHumanMedicinesPaediatrics
European Medicines Agency recommends lifting suspension of aprotinin 17 februar 2012Press releaseHumanMedicines
European Medicines Agency recommends new contraindications and warnings for aliskiren-containing medicines 17 februar 2012Press releaseHumanMedicines
European Medicines Agency gives final recommendations for 12 centrally authorised medicines manufactured at Ben Venue Laboratories 16 februar 2012Press releaseHumanMedicines
European Medicines Agency informs doctors and patients about drug interaction between Victrelis and ritonavir-boosted HIV protease inhibitors 16 februar 2012Press releaseHumanMedicines
European Medicines Agency confirms positive benefit-risk balance of orlistat-containing medicines 16 februar 2012Press releaseHumanMedicines